| Product Code: ETC5243839 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antibiotic Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antibiotic Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antibiotic Market - Industry Life Cycle |
3.4 Israel Antibiotic Market - Porter's Five Forces |
3.5 Israel Antibiotic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Antibiotic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Antibiotic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Antibiotic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Antibiotic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Israel |
4.2.2 Growing awareness about the importance of appropriate antibiotic use |
4.2.3 Technological advancements in antibiotic development and manufacturing |
4.3 Market Restraints |
4.3.1 Rising concerns about antibiotic resistance |
4.3.2 Stringent regulations and guidelines for antibiotic usage |
4.3.3 Competition from alternative treatment options such as probiotics and phage therapy |
5 Israel Antibiotic Market Trends |
6 Israel Antibiotic Market Segmentations |
6.1 Israel Antibiotic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Antibiotic Market Revenues & Volume, By Penicillin, 2021-2031F |
6.1.3 Israel Antibiotic Market Revenues & Volume, By Cephalosporin, 2021-2031F |
6.1.4 Israel Antibiotic Market Revenues & Volume, By Aminoglycosides, 2021-2031F |
6.1.5 Israel Antibiotic Market Revenues & Volume, By Tetracycline, 2021-2031F |
6.1.6 Israel Antibiotic Market Revenues & Volume, By Macrolides, 2021-2031F |
6.1.7 Israel Antibiotic Market Revenues & Volume, By Fluoroquinolones, 2021-2031F |
6.1.9 Israel Antibiotic Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Israel Antibiotic Market Revenues & Volume, By Others, 2021-2031F |
6.2 Israel Antibiotic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Antibiotic Market Revenues & Volume, By Skin Infections, 2021-2031F |
6.2.3 Israel Antibiotic Market Revenues & Volume, By Respiratory Infections, 2021-2031F |
6.2.4 Israel Antibiotic Market Revenues & Volume, By Urinary Tract Infections, 2021-2031F |
6.2.5 Israel Antibiotic Market Revenues & Volume, By Septicemia, 2021-2031F |
6.2.6 Israel Antibiotic Market Revenues & Volume, By Ear Infection, 2021-2031F |
6.2.7 Israel Antibiotic Market Revenues & Volume, By Gastrointestinal Infections, 2021-2031F |
6.3 Israel Antibiotic Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Antibiotic Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Israel Antibiotic Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Israel Antibiotic Market Revenues & Volume, By Others, 2021-2031F |
6.4 Israel Antibiotic Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Antibiotic Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.4.3 Israel Antibiotic Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.4.4 Israel Antibiotic Market Revenues & Volume, By Online Pharmacy, 2021-2031F |
7 Israel Antibiotic Market Import-Export Trade Statistics |
7.1 Israel Antibiotic Market Export to Major Countries |
7.2 Israel Antibiotic Market Imports from Major Countries |
8 Israel Antibiotic Market Key Performance Indicators |
8.1 Rate of antibiotic prescriptions per capita |
8.2 Percentage of antibiotic-resistant infections in healthcare settings |
8.3 Research and development investment in new antibiotic formulations |
8.4 Number of antibiotic stewardship programs implemented in healthcare facilities |
8.5 Patient education initiatives on responsible antibiotic use and adherence to treatment protocols |
9 Israel Antibiotic Market - Opportunity Assessment |
9.1 Israel Antibiotic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Antibiotic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Antibiotic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Antibiotic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Antibiotic Market - Competitive Landscape |
10.1 Israel Antibiotic Market Revenue Share, By Companies, 2024 |
10.2 Israel Antibiotic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |